<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01291134</url>
  </required_header>
  <id_info>
    <org_study_id>PRO-000053</org_study_id>
    <nct_id>NCT01291134</nct_id>
  </id_info>
  <brief_title>PureGen: A Radiographic Analysis of Rate and Quality of Fusion in Patients Undergoing Anterior Cervical Discectomy and Fusion (ACDF)</brief_title>
  <official_title>PureGen Osteoprogenitor Cell Allograft: A Radiographic Analysis of Rate and Quality of Fusion in Patients Undergoing Anterior Cervical Discectomy and Fusion (ACDF)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Alphatec Spine, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Alphatec Spine, Inc.</source>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the rate and quality of spinal fusion utilizing&#xD;
      PureGen Osteoprogenitor Cell Allograft in Anterior Cervical Discectomy and Fusion (ACDF).&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    PureGen was taken off of the market&#xD;
  </why_stopped>
  <start_date>February 2011</start_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Fusion</measure>
    <time_frame>12 months</time_frame>
    <description>Proportion of subjects with fusion at the 12-month visit</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Cervical Degenerative Disc Disease</condition>
  <arm_group>
    <arm_group_label>Cervical Degenerative Disc Disease</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>PureGen Osteoprogenitor Cell Allograft</intervention_name>
    <description>PureGen Osteoprogenitor Cell Allograft.</description>
    <arm_group_label>Cervical Degenerative Disc Disease</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Subjects suffering from symptoms of cervical degenerative disc disease (DDD) in one to four&#xD;
        contiguous levels between C3 and T1.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Persistent neck and/or arm pain consistent to symptomatic cervical degenerative disc&#xD;
             disease&#xD;
&#xD;
          -  Moderate Neck Disability Index&#xD;
&#xD;
          -  Unresponsive to conservative treatment for at least 6 weeks&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  More than 4 levels requiring surgical treatment&#xD;
&#xD;
          -  Prior failed fusion surgery at the index level(s)&#xD;
&#xD;
          -  Systemic or local infection in the disc or cervical spine, past or present&#xD;
&#xD;
          -  Active systemic disease&#xD;
&#xD;
          -  Osteoporosis, osteomalacia, or other metabolic bone disease that would significantly&#xD;
             inhibit bone healing&#xD;
&#xD;
          -  Known or suspected history of alcohol and/or drug abuse&#xD;
&#xD;
          -  Involved in pending litigation or worker's compensation relating to the spine&#xD;
&#xD;
          -  Pregnant or plans to become pregnant during the duration of the study&#xD;
&#xD;
          -  Insulin-dependent diabetes mellitus&#xD;
&#xD;
          -  Life expectancy less than study duration&#xD;
&#xD;
          -  Any significant psychological disturbance that in the opinion of the Investigator&#xD;
             could impair consent process or ability to complete self-assessment questionnaires&#xD;
&#xD;
          -  BMI greater than 40&#xD;
&#xD;
          -  Undergoing chemotherapy or radiation treatment, or chronic use of oral or injected&#xD;
             steroids or prolonged use of non-steroidal anti-inflammatory drugs&#xD;
&#xD;
          -  Known history of hypersensitivity or anaphylactic reaction to dimethyl sulfoxide&#xD;
             (DMSO).&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <address>
        <city>Beverly Hills</city>
        <state>California</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Middleton</city>
        <state>Connecticut</state>
        <zip>06457</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Greensboro</city>
        <state>North Carolina</state>
        <zip>27401</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Raleigh</city>
        <state>North Carolina</state>
        <zip>27607</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>December 2013</verification_date>
  <study_first_submitted>February 4, 2011</study_first_submitted>
  <study_first_submitted_qc>February 7, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 8, 2011</study_first_posted>
  <last_update_submitted>December 31, 2013</last_update_submitted>
  <last_update_submitted_qc>December 31, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 3, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Intervertebral Disc Degeneration</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

